Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
LIHC | rs11536974 | chr20:36992124 | C/T | 8.88E-16 | 368 | 19.95 | 18.8 | 0.53 | KM Plot |
LIHC | rs11536987 | chr20:37000749 | G/A | 1.67E-15 | 363 | 20.03 | 18.8 | 0.53 | KM Plot |
LIHC | rs11536990 | chr20:37001274 | T/C | 1.78E-15 | 362 | 20.03 | 18.8 | 0.53 | KM Plot |
LIHC | rs115999861 | chr5:147028293 | T/C | 1.84E-5 | 365 | 20.05 | 16.2 | 4.25 | KM Plot |
LIHC | rs116729113 | chr5:126172804 | C/G | 3.42E-5 | 364 | 19.83 | 12.17 | 2.23 | KM Plot |
LIHC | rs11674211 | chr2:37167497 | A/G | 1.1E-5 | 363 | 20.5 | 12.17 | 8.73 | KM Plot |
LIHC | rs11676225 | chr2:37126159 | C/G | 8.8E-6 | 368 | 8.73 | 12.17 | 20.45 | KM Plot |
LIHC | rs11678303 | chr2:37122136 | C/T | 8.8E-6 | 368 | 20.45 | 12.17 | 8.73 | KM Plot |
LIHC | rs11682966 | chr2:37121894 | T/C | 8.8E-6 | 368 | 20.45 | 12.17 | 8.73 | KM Plot |
LIHC | rs11685600 | chr2:37190392 | G/C | 1.05E-5 | 358 | 20.45 | 13.2 | 8.73 | KM Plot |
LIHC | rs11686605 | chr2:37164743 | T/G | 1.1E-5 | 366 | 20.45 | 12.17 | 8.73 | KM Plot |
LIHC | rs11690477 | chr2:37223886 | C/T | 2.36E-5 | 363 | 20.27 | 14.9 | 8.73 | KM Plot |
LIHC | rs11691236 | chr2:37167442 | T/C | 1.1E-5 | 366 | 20.45 | 12.17 | 8.73 | KM Plot |
LIHC | rs117747451 | chr2:37159794 | G/C | 1.1E-5 | 366 | 20.45 | 12.17 | 8.73 | KM Plot |
LIHC | rs11844511 | chr14:73692895 | A/T | 1.72E-6 | 364 | 20.27 | 12.1 | 4.93 | KM Plot |